cyproterone acetate has been researched along with Adenocarcinoma in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (22.22) | 18.7374 |
| 1990's | 25 (46.30) | 18.2507 |
| 2000's | 10 (18.52) | 29.6817 |
| 2010's | 7 (12.96) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerný, D; Röderová, E; Sálek, T; Vodička, M | 1 |
| Antoniou, N; Calais da Silva, F; Calais da Silva, FM; Gonçalves, F; Kliment, J; Marques Queimadelos, A; Oliver, T; Pastidis, S; Robertson, C; Santos, A; Whelan, P | 1 |
| Bouchard, P; Irani, J; Mottet, N; Oba, R; Salomon, L | 1 |
| Bosland, MC; Johnson, WD; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Bernier, J; Billiet, I; Bolla, M; Collette, L; Cutajar, CL; Dubois, JB; Kuten, A; Mirimanoff, RO; Pfeffer, R; Sternberg, C; Storme, G; Torecilla, JL; Van der Kwast, T; Van Tienhoven, G; Warde, P | 1 |
| D'Amico, AV | 1 |
| Bagatini, MD; Battisti, IE; Battisti, V; Chiesa, J; Duarte, MM; Gonçalves, JF; Maders, LD; Morsch, VM; Reetz, LG; Schetinger, MR | 1 |
| Bullock, MJ; Goldenberg, SL; Klotz, LH; Srigley, JR | 1 |
| Lotti, T; Montironi, R; Polito, M; Prezioso, D | 3 |
| Baltogiannis, D; Charalabopoulos, K; Giannakopoulos, X; Sofikitis, N | 1 |
| Chang, CY; Elbi, C; Hager, GL; Hendarwanto, A; Klokk, TI; Kurys, P; Nagaich, AK; Saatcioglu, F; Slagsvold, T | 1 |
| Bruchovsky, N; Crook, J; Goldenberg, SL; Klotz, L | 1 |
| Costa, J; Miquel, M; Ojanguren, I; Planas, R; Soler, A; Vaqué, A | 1 |
| Isaacs, JT | 1 |
| Bosland, MC; Kroes, R; Prinsen, MK | 1 |
| Aakvaag, A; Nissen-Meyer, R; Sander, S | 1 |
| Allen, JM; Bloom, SR; Kerle, D; O'Shea, JP; Smith, C; Williams, G; Yeo, T | 1 |
| Aus, G; Busch, C; de la Torre, M; Elvin, A; Häggman, M; Hellström, M; Pedersen, K; Stege, R; Tisell, A; Wijkström, H | 1 |
| Akakura, K; Bruchovsky, N; Buckley, AR; Goldenberg, SL; Rennie, PS; Sullivan, LD | 1 |
| Culine, S; Droz, JP; Elias, D; Kattan, J; Spatz, A; Terrier-Lacombe, MJ | 1 |
| Berrevoets, CA; Mulder, E; Veldscholte, J | 1 |
| Battisti, E; Fattorini, L; Fioravanti, A; Giordano, N; Magaro, L; Marcolongo, R; Marcucci, P | 1 |
| de Pauw, M; Newling, DW; Richards, B; Robinson, MR; Smith, PH; Sylvester, R | 1 |
| Azmatullah, S; Fellows, GJ; Gingell, JC; O'Boyle, PJ; Thorpe, SC | 1 |
| Andert, S; Dürer, A; Haberl, I; Hamilton, G; Holub, S; Theyer, G; Theyer, U | 1 |
| Gurpide, E; Markiewicz, L | 1 |
| Bernier, J; Bolla, M; Collette, L; Dubois, JB; Gil, T; Gonzalez, D; Kuten, A; Mirimanoff, RO; Pierart, M; Sternberg, C; Storme, G; Warde, P | 1 |
| Orhan, D; Ozdiler, E; Sak, SD; Tulunay, O; Yaman, O | 1 |
| Goldenberg, SL; Klotz, LH; Rabbani, F | 1 |
| Bosland, MC; Johnson, WD; Kelloff, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Di Chiro, C; Di Silverio, F; Sciarra, A | 1 |
| Bissett, JD; Macdonald, AG | 1 |
| Gennari, C; Geraci, S; Giordano, N; Nardi, P; Santacroce, C | 1 |
| Abbar, M; Ameur, A; el Alami, M; el Mostarchid, B; Jira, H; Touiti, D | 1 |
| Aubert, J; Bon, D; Dore, B; Irani, J | 1 |
| Bonnesen, T; Frimodt-Møller, C; Nilsson, T; Ostri, P | 1 |
| García Vicente, C; Lobato Encinas, JJ; Megías Garrigos, J; Mira Llinares, A; Pelluch Auladell, A; Pérez-Llorca, LA; Romero Pérez, P | 1 |
| Fidison, A; Radesa, F; Radio, C; Zafy, A | 1 |
| Antoni, M; Botta-Fridlund, D; Bourlière, M; Gauthier, A; Maillot, A; Toullec, J | 1 |
| Bosland, MC; Prinsen, MK | 1 |
| Dornschneider, G; Eibl-Eibesfeldt, B; Hamilton, SR; Harnisch, E; Izbicki, JR; Schweiberer, L; Wambach, G; Wilker, DK | 1 |
| Braude, S; Taylor, H | 1 |
| Blake, JC; Dooley, JS; McIntyre, N; Sawyerr, AM; Scheuer, PJ | 1 |
| Aubert, J; Dore, B; Irani, J; Orget, J | 1 |
| Hartmann, A; Mann, K | 1 |
| Cochrane, AM; Gazzard, BG; Johnson, PJ; Keating, JJ; Krasner, N; Smith, PM; Trewby, PN; Wheeler, P; Wilkinson, SP; Williams, R | 1 |
| Bonini, R; Papineschi, F; Pistolisi, D; Spremolla, G | 1 |
| Cunningham, GR; Shao, TC; Tindall, DJ | 1 |
| Bolt, J; Brinkmann, AO; de Boer, W; Kuiper, GG; Mulder, E; van Steenbrugge, GJ | 1 |
| Robinson, MR | 1 |
| Alund, G; Varenhorst, E | 1 |
3 review(s) available for cyproterone acetate and Adenocarcinoma
| Article | Year |
|---|---|
Monotherapy in advanced prostate cancer: an overview.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Dihydrotestosterone; Estrogens; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Nitriles; Orchiectomy; Palliative Care; Progesterone Congeners; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Testosterone; Tosyl Compounds | 2004 |
Hepatocellular carcinoma during hormonotherapy for prostatic cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cyproterone Acetate; Humans; Liver Neoplasms; Male; Neoplasms, Second Primary; Prostatic Neoplasms; Triptorelin Pamoate | 1994 |
[Exophthalmos caused by orbital metastasis of prostatic carcinoma].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Exophthalmos; Humans; Male; Orbital Neoplasms; Orchiectomy; Palliative Care; Prostatic Neoplasms | 1991 |
17 trial(s) available for cyproterone acetate and Adenocarcinoma
| Article | Year |
|---|---|
Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the South European Uroncological Group.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyproterone Acetate; Disease Progression; Europe; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Sexuality; Survival Rate; Time Factors; Triptorelin Pamoate | 2014 |
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Topics: Adenocarcinoma; Androgen Antagonists; Autonomic Agents; Cyclohexanols; Cyproterone Acetate; Double-Blind Method; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Canada; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cyproterone Acetate; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Europe; Fractures, Bone; Goserelin; Humans; Israel; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Staging; Prostatic Neoplasms; Risk Assessment; Russia; Time Factors; Treatment Outcome | 2010 |
Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial.
Topics: Adenocarcinoma; Antineoplastic Agents; Cyproterone Acetate; Humans; Male; Middle Aged; Neoadjuvant Therapy; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Treatment Outcome | 2002 |
Neoadjuvant hormone treatment with leuprolide acetate depot 3.75 mg and cyproterone acetate, before radical prostatectomy: a randomized study.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyproterone Acetate; Delayed-Action Preparations; Humans; Leuprolide; Male; Middle Aged; Preoperative Care; Prostatectomy; Prostatic Neoplasms | 2004 |
Locally advanced prostate cancer--biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyproterone Acetate; Humans; Leuprolide; Male; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy; Testosterone | 2007 |
Orchiectomy combined with cyproterone acetate or prednisone in the treatment of advanced prostatic carcinoma. A randomized clinical and endocrine study.
Topics: Adenocarcinoma; Aged; Castration; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Humans; Male; Prednisone; Prostatic Neoplasms; Random Allocation | 1982 |
The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of t
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Humans; Male; Orchiectomy; Prostatic Neoplasms; Survival Rate; Time Factors | 1995 |
A prospective, randomised study to compare goserelin acetate (Zoladex) versus cyproterone acetate (Cyprostat) versus a combination of the two in the treatment of metastatic prostatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyproterone Acetate; Disease Progression; Goserelin; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Safety | 1996 |
Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy.
Topics: Adenocarcinoma; Androgen Antagonists; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyproterone Acetate; Drug Administration Schedule; Goserelin; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tissue Polypeptide Antigen | 1997 |
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyproterone Acetate; Goserelin; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Survival Analysis; Treatment Outcome | 1997 |
Predictors of pathological stage before neoadjuvant androgen withdrawal therapy and radical prostatectomy. The Canadian Urologic Oncology Group.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Chi-Square Distribution; Cyproterone Acetate; Humans; Logistic Models; Male; Multivariate Analysis; Neoplasms, Hormone-Dependent; Prognosis; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 1998 |
Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer. Takeda NHT Italian Group.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyproterone Acetate; Delayed-Action Preparations; Diagnosis, Differential; Disease-Free Survival; Drug Administration Schedule; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms | 1998 |
Role of neoadjuvant treatment in clinically confined prostate cancer. Takeda NHT Italian Group.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyproterone Acetate; Diagnosis, Differential; Humans; Leuprolide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms | 1999 |
Treatment of symptomatic metastatic prostatic cancer with cyproterone acetate versus orchiectomy: a prospective randomized trial.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Cyproterone; Cyproterone Acetate; Humans; Male; Middle Aged; Orchiectomy; Palliative Care; Prospective Studies; Prostatic Neoplasms | 1991 |
A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Tamoxifen | 1989 |
EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
Topics: Adenocarcinoma; Clinical Protocols; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Humans; Male; Orchiectomy; Prostatic Neoplasms | 1988 |
34 other study(ies) available for cyproterone acetate and Adenocarcinoma
| Article | Year |
|---|---|
[Hepatotoxicity induced by cyproteron acetate in the prostate carcinoma treatment - a case report].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents; Cyproterone Acetate; Humans; Liver Failure, Acute; Male; Prostatic Neoplasms | 2013 |
Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.
Topics: Adenocarcinoma; Alkylating Agents; alpha-Tocopherol; Androgens; Animals; Antioxidants; Cyproterone Acetate; Disease Models, Animal; Drug Therapy, Combination; Male; Methylnitrosourea; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Rats, Wistar; Selenium Compounds; Selenomethionine; Testosterone; Vitamin E | 2010 |
Is long-term androgen suppression right for everyone with locally advanced prostate cancer?
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cyproterone Acetate; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Fractures, Bone; Goserelin; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Prostatic Neoplasms; Risk Assessment; Time Factors; Treatment Outcome | 2010 |
Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Ascorbic Acid; Bone Neoplasms; Catalase; Cyproterone Acetate; Erythrocytes; Goserelin; Humans; Lipid Peroxidation; Male; Middle Aged; Neoplasm Grading; Oxidative Stress; Prostatic Neoplasms; Protein Carbonylation; Sulfhydryl Compounds; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2011 |
Ligand-specific dynamics of the androgen receptor at its response element in living cells.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cyproterone Acetate; Dihydrotestosterone; Female; Fluorescence Recovery After Photobleaching; Flutamide; Genes, Reporter; Green Fluorescent Proteins; In Situ Hybridization, Fluorescence; Ligands; Luciferases; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Metribolone; Mice; Microscopy, Video; Mifepristone; Models, Biological; Nitriles; Plasmids; Promoter Regions, Genetic; Receptors, Androgen; Response Elements; Testosterone; Tosyl Compounds; Transcription, Genetic | 2007 |
Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
Topics: Acute Disease; Adenocarcinoma; Adrenal Cortex Hormones; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Cyproterone Acetate; Drug Monitoring; Flutamide; Humans; Liver; Liver Function Tests; Male; Prostatic Neoplasms; Severity of Illness Index; Treatment Outcome | 2007 |
Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.
Topics: Adenocarcinoma; Animals; Castration; Cell Division; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Kinetics; Male; Neoplasms, Experimental; Prostatic Neoplasms; Rats | 1982 |
Adenocarcinomas of the prostate induced by N-nitroso-N-methylurea in rats pretreated with cyproterone acetate and testosterone.
Topics: Adenocarcinoma; Animals; Carcinoma in Situ; Cocarcinogenesis; Cyproterone; Cyproterone Acetate; Male; Methylnitrosourea; Models, Biological; Neoplasm Metastasis; Neoplasms, Experimental; Nitrosourea Compounds; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testosterone | 1983 |
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Topics: Adenocarcinoma; Buserelin; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1984 |
[Treatment of prostatic cancer].
Topics: Adenocarcinoma; Aged; Brachytherapy; Cesium Radioisotopes; Cyproterone; Cyproterone Acetate; Estrogens; Gonadotropin-Releasing Hormone; Humans; Iridium; Lymph Node Excision; Male; Middle Aged; Orchiectomy; Prostatectomy; Prostatic Neoplasms; Triptorelin Pamoate | 1984 |
Neoadjuvant GnRH-agonist treatment (triptorelin and cyproterone acetate for flare protection) and total prostatectomy.
Topics: Adenocarcinoma; Aged; Combined Modality Therapy; Cyproterone Acetate; Drug Therapy, Combination; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1993 |
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Cyproterone Acetate; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasm Staging; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1993 |
Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Topics: Adenocarcinoma; Alanine; Amino Acid Sequence; Androgen Antagonists; Anilides; Animals; Blotting, Western; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Cyproterone Acetate; Dose-Response Relationship, Drug; Flutamide; Humans; Male; Metribolone; Mutagenesis, Site-Directed; Nitriles; Point Mutation; Prostatic Neoplasms; Receptors, Androgen; Recombinant Proteins; Threonine; Tosyl Compounds; Transcription, Genetic; Transfection; Transformation, Genetic; Tumor Cells, Cultured | 1993 |
Systemic sclerosis following anti-androgenic treatment for prostatic adenocarcinoma.
Topics: Adenocarcinoma; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Cyproterone Acetate; Humans; Male; Methylprednisolone; Middle Aged; Orchiectomy; Prostatic Neoplasms; Scleroderma, Systemic | 1993 |
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured | 1997 |
Carcinosarcoma of the prostate. A case report and a possible evidence on the role of hormonal therapy.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents; Carcinosarcoma; Cyproterone Acetate; Humans; Immunohistochemistry; Male; Neoplasms, Multiple Primary; Prostatectomy; Prostatic Neoplasms; Receptors, Progesterone | 1997 |
Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Carcinoma; Cyproterone Acetate; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Male; Methylnitrosourea; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone; Time Factors | 1999 |
Intermittent androgen deprivation (IAD) in patients with biochemical failure after radical retropubic prostatectomy (RRP) for clinically localized prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyproterone Acetate; Humans; Lymph Nodes; Male; Middle Aged; Postoperative Care; Prospective Studies; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Treatment Outcome; Triptorelin Pamoate | 2000 |
Avascular necrosis of the femoral head in patients with prostate cancer treated with cyproterone acetate and radiotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Cyproterone Acetate; Diagnosis, Differential; Femur Head Necrosis; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiotherapy | 2001 |
Acute hepatitis induced by cyproterone acetate.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Cyproterone Acetate; Humans; Male; Prostatic Neoplasms | 2001 |
[Brain metastasis of prostatic cancer: regression under hormonal treatment].
Topics: Adenocarcinoma; Adult; Androgen Antagonists; Brain Neoplasms; Cyproterone Acetate; Fatal Outcome; Humans; Male; Prostatic Neoplasms; Remission Induction | 2001 |
[Cancers of the prostate and cyproterone acetate. Value of blood testosterone and PSA levels for treatment surveillance].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antigens, Neoplasm; Cyproterone; Cyproterone Acetate; Follow-Up Studies; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Testosterone | 1990 |
[Stenosis of the rectum. A rare complication of prostatic cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Barium Sulfate; Cyproterone; Cyproterone Acetate; Enema; Humans; Male; Prostatic Neoplasms; Radiography; Rectal Diseases; Rectum | 1991 |
[Fatal subfulminant hepatitis caused by cyproterone acetate].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Cyproterone; Cyproterone Acetate; Humans; Male; Prostatic Neoplasms | 1991 |
Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl after sequential treatment
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Aminobiphenyl Compounds; Animals; Body Weight; Cyproterone; Cyproterone Acetate; Genitalia, Male; Male; Methylnitrosourea; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Sarcoma, Experimental; Survival Analysis; Testosterone | 1990 |
Effects of androgen manipulations on chemically induced colonic tumours and on macroscopically normal colonic mucosa in male Sprague-Dawley rats.
Topics: Adenocarcinoma; Animals; Azoxymethane; Colonic Neoplasms; Cyproterone; Cyproterone Acetate; Drug Synergism; Intestinal Mucosa; Male; Mitotic Index; Orchiectomy; Rats; Rats, Inbred Strains; Testosterone | 1990 |
Lobar collapse due to endobronchial metastatic prostatic carcinoma: re-expansion with antiandrogen treatment.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Humans; Lung; Lung Neoplasms; Male; Prostatic Neoplasms; Pulmonary Atelectasis | 1990 |
Severe hepatitis caused by cyproterone acetate.
Topics: Adenocarcinoma; Aged; Aspartate Aminotransferases; Bilirubin; Chemical and Drug Induced Liver Injury; Cyproterone; Cyproterone Acetate; Humans; Liver; Male; Prostatic Neoplasms | 1990 |
[Hepatitis after treatment with cyproterone acetate. Apropos of a case].
Topics: Adenocarcinoma; Aged; Chemical and Drug Induced Liver Injury; Cyproterone; Cyproterone Acetate; Humans; Male; Prostatic Neoplasms | 1990 |
[Therapy with LHRH analogs in a 41-year-old patient with metastatic breast cancer].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Femoral Neoplasms; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Male; Tamoxifen; Triptorelin Pamoate | 1989 |
[Chronic myeloid leukemia and carcinoma of the prostate].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Busulfan; Cyproterone; Cyproterone Acetate; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasms, Multiple Primary; Prostatic Neoplasms; Remission Induction | 1989 |
Age dependency of androgen and estrogen effects on incorporation of (3H)-thymidine by rat prostates in organ culture.
Topics: Adenocarcinoma; Age Factors; Androgens; Animals; Cyproterone; Cyproterone Acetate; Estradiol; Estrogens; Insulin; Male; Mice; Organ Culture Techniques; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testosterone | 1986 |
Characterization of androgen receptors in a transplantable human prostatic adenocarcinoma (PC-82).
Topics: Adenocarcinoma; Cell Line; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Estradiol; Estrenes; Humans; Male; Metribolone; Molecular Weight; Neoplasm Transplantation; Progesterone; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Triamcinolone Acetonide | 1987 |
Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment.
Topics: Adenocarcinoma; Aged; Castration; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms; Urethral Obstruction | 1985 |